What Your Health Labs Are NOT Doing, and How Precision Genetics Is Taking Care of You

Precision Genetics has partnered with many strong, dedicated health systems to be part of the impact on fighting the COVID-19 pandemic this year. Precision Genetics is doing what we can to lessen what is a high demand with COVID right now. Everyone is seeing spikes and supply shortages. Precision has not encountered a supply shortage or a backlog because of our unique operational efficiency.

Our latest venture brings our story to national news media so others can hear how they can benefit from fast, accurate and reliable testing and results in a time of shortages and long waits.  You can find us in Mediaplanet’s Fighting the Flu campaign, out today!

Learn More

Precision Genetics Launches Combination Test to Detect COVID-19 and the Flu

Precision Genetics has developed a test that can detect the presence of both COVID-19 and the Flu (Influenza A and B) from a single sample.  The combination makes diagnosing the cause of a patient’s symptoms clear for patients and providers.  “By utilizing our high-complexity laboratory and testing methods, we can quickly and accurately distinguish between these viral infections,” said Nate Wilbourne, founder and CEO of Precision Genetics.


Learn More

Precision Genetics Advances COVID-19 Testing by Adding Saliva Collection Under Existing EUA

Precision Genetics has added saliva collection to its existing portfolio of validated COVID-19 testing options under the existing Food and Drug Administration emergency use authorization. This advancement comes at a time when people have become increasingly more resistant to the idea of nasopharyngeal (NP) swab testing. Saliva collection requires the patient to expel their saliva into a tube, making it far less invasive than the standard nasopharyngeal collection method.

Learn More

SCRA Announces a $250,000 SC Launch, Inc. Investment in Precision Genetics.

SCRA has provided a $250,000 investment in Precision Genetics through SC Launch to help the company expand its processing of COVID-19 test kits.

“SCRA: South Carolina Research Authority and #SCLaunchInc. stepped up and provided financial commitment and strategic support for us to expedite our efforts. We are desperately trying to serve our community in this time of need, and we are very grateful for the support from SCRA and SC Launch, Inc.” said Nate Wilbourne, CEO of Precision Genetics.

Learn more here.

Precision Genetics and the City of Columbia SC Collaborate to Make Tests Available to First Responders

Precision Genetics and the City of Columbia SC are collaborating to make tests available to first responders in the City of Columbia.

“We are going to start with first responders and front-line staff,” Mayor Steve Benjamin says. “So, with them and their families, particularly if we know they have been exposed to the virus, or are symptomatic. Our first focus will be inward, on the city. But, we have the ability also to respond to local emergencies, if one were to emerge, and provide testing through our infrastructure.”

Learn more here.

Precision Genetics Validated EUA Process for COVID-19 Test Kits

On April 3, 2020, Precision Genetics validated the Emergency Use Authorization (EUA) via the Food and Drug Administration (FDA) to process COVID-19 test kits. Precision Genetics is now available to support state and local healthcare systems in need of public health surveillance and has priority access to test reagents from commercial reagent manufacturers which have received EUA from the FDA.

Precision Genetics provides the test kits for healthcare facilities and providers looking to test patients using real-time RT-polymerase chain reaction (RT-PCR) detection of the SARS-CoV-2 virus (the virus that causes COVID-19) in respiratory specimens. The test uses RT-PCR to detect the virus in upper and lower respiratory specimens.

Test results are intended to be interpreted by a licensed physician or other licensed healthcare professional. Results from this test are not intended to take the place of professional medical advice. Decisions regarding course of medical treatment must be made only after consulting with a licensed physician or other licensed healthcare professional, and should consider each patient’s medical history.

Currently, results will be available within 24 hours (1 business day) from time of receipt of the sample in the laboratory, with plans to boost testing capacity in the coming week. Precision Genetics’ healthcare technology laboratory has the capability to direct-connect to other laboratories, healthcare systems, and practitioner’s offices so to deliver test information within seconds of the results being reported. The laboratory uses cloud-based information system,, to help expedite the test orders, specimen tracking and resulting to support faster response times to the COVID-19 pandemic.

If you have any inquiries, please contact us at (877) 843-6544 ext. 4 or email us at